Construct Validity of Inherited Retinal Disease-Specific Patient-Reported Outcome Measures

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorJAYASUNDERA, K. Thiran
dc.contributor.authorABUZAITOUN, Rebhi O.
dc.contributor.authorPOPOVA, Lilia
dc.contributor.authorABALEM, Maria Fernanda
dc.contributor.authorANDREWS, Chris A.
dc.contributor.authorLACY, Gabrielle D.
dc.contributor.authorFRESCO, David M.
dc.contributor.authorMUSCH, David C.
dc.date.accessioned2024-04-05T19:39:36Z
dc.date.available2024-04-05T19:39:36Z
dc.date.issued2023
dc.description.abstractPURPOSE: To evaluate aspects of construct validity of the Michigan Retinal Degeneration Questionnaire (MRDQ) and the Michigan Vision-related Anxiety Ques-tionnaire (MVAQ). center dot METHODS: Subjects with a clinical diagnosis of an inherited retinal disease (IRD) were recruited prospec-tively and 3 tests were used to assess construct valid-ity: the ability to distinguish different IRD phenotypes; test a priori hypothesis of an association between vision-related anxiety and vision-related disabilities; and corre-late MRDQ and MVAQ with the National Eye Insti-tute Visual Functioning Questionnaire 25 (NEI VFQ-25) and the Impact of Vision Impairment (IVI). One-way analysis of variance (ANOVA) was used to com-pare different phenotypes for mean domain scores for MRDQ/MVAQ. Pearson correlations were performed be-tween; Cone-Function Anxiety and Central Vision con-trolling for better eye visual acuity, Rod-Function Anxi-ety and Scotopic Function controlling for visual field area (III4e and IV4e), and scores of MRDQ/MVAQ, NEI VFQ-25, and IVI. center dot RESULTS: The study sample consisted of 146 pa-tients evenly divided between males and females, and mean age was 50 years. The 1-way ANOVA test was significant for distinguishing IRD phenotypes in 6 do-mains of MRDQ/MVAQ. Cone-Function Anxiety corre-lated with Central Vision controlling for visual acuity, Rod-Function Anxiety correlated with Scotopic Func-tion controlling for visual field area, and all domains in MRDQ/MVAQ had significant correlations with NEI VFQ-25 and IVI composite scores. center dot CONCLUSION: MRDQ and MVAQ domenstrate aspects of construct-validity set forth by the US Food and Drug Administration. The study futher supports the use of both patient-reported outcome measures in IRD clinical trials and natural history studies. (Am J Ophthalmol 2023;248: 116-126. (c) 2022 Elsevier Inc. All rights re-served.)eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexScopus
dc.description.indexDimensions
dc.description.indexWoS
dc.description.sponsorshipNational Eye Institute [K23EY026985]
dc.identifier.citationAMERICAN JOURNAL OF OPHTHALMOLOGY, v.248, p.116-126, 2023
dc.identifier.doi10.1016/j.ajo.2022.11.021
dc.identifier.eissn1879-1891
dc.identifier.issn0002-9394
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/59208
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INCeng
dc.relation.ispartofAmerican Journal of Ophthalmology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright ELSEVIER SCIENCE INCeng
dc.subject.othermental-healtheng
dc.subject.otherquestionnaireeng
dc.subject.otheranxietyeng
dc.subject.otherruminationeng
dc.subject.otherbehaviorseng
dc.subject.otherstresseng
dc.subject.otherworryeng
dc.subject.otherlifeeng
dc.subject.wosOphthalmologyeng
dc.titleConstruct Validity of Inherited Retinal Disease-Specific Patient-Reported Outcome Measureseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.author.externalJAYASUNDERA, K. Thiran:Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI USA; Univ Michigan, Kellogg Eye Ctr, Retinal Dystrophy Clin, Ann Arbor, MI 48104 USA
hcfmusp.author.externalABUZAITOUN, Rebhi O.:Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI USA
hcfmusp.author.externalPOPOVA, Lilia:Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI USA
hcfmusp.author.externalANDREWS, Chris A.:Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI USA
hcfmusp.author.externalLACY, Gabrielle D.:Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI USA
hcfmusp.author.externalFRESCO, David M.:Univ Michigan, Dept Psychiat, Ann Arbor, MI USA
hcfmusp.author.externalMUSCH, David C.:Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI USA
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcMARIA FERNANDA ABALEM DE SA CARRICONDO
hcfmusp.description.beginpage116
hcfmusp.description.endpage126
hcfmusp.description.volume248
hcfmusp.origemWOS
hcfmusp.origem.dimensionspub.1153364783
hcfmusp.origem.pubmed36470512
hcfmusp.origem.scopus2-s2.0-85146935249
hcfmusp.origem.wosWOS:000962933900001
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAhn DH, 2015, ANN REHABIL MED-ARM, V39, P74, DOI 10.5535/arm.2015.39.1.74eng
hcfmusp.relation.referenceBLATT SJ, 1995, AM PSYCHOL, V50, P1003, DOI 10.1037/0003-066X.50.12.1003eng
hcfmusp.relation.referenceBrosschot JF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030464eng
hcfmusp.relation.referenceCacioppo JT, 2015, ANNU REV PSYCHOL, V66, P733, DOI 10.1146/annurev-psych-010814-015240eng
hcfmusp.relation.referenceCacioppo S, 2015, PERSPECT PSYCHOL SCI, V10, P238, DOI 10.1177/1745691615570616eng
hcfmusp.relation.referenceClancy F, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhurn.2016.00534eng
hcfmusp.relation.referenceDickman SL, 2017, LANCET, V389, P1431, DOI 10.1016/S0140-6736(17)30398-7eng
hcfmusp.relation.referenceEisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086eng
hcfmusp.relation.referenceFDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79eng
hcfmusp.relation.referenceFresco DM, 2019, CURR OPIN PSYCHOL, V28, P65, DOI 10.1016/j.copsyc.2018.10.014eng
hcfmusp.relation.referenceGarip G, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1169-zeng
hcfmusp.relation.referenceHenderson N, 2000, LANCET, V356, pS18, DOI 10.1016/S0140-6736(00)92004-Xeng
hcfmusp.relation.referenceJackson JS, 2010, AM J PUBLIC HEALTH, V100, P933, DOI 10.2105/AJPH.2008.143446eng
hcfmusp.relation.referenceKertz SJ, 2014, PSYCHOL ASSESSMENT, V26, P1146, DOI 10.1037/a0037251eng
hcfmusp.relation.referenceKing AP, 2019, CURR OPIN PSYCHOL, V28, P285, DOI 10.1016/j.copsyc.2019.02.009eng
hcfmusp.relation.referenceLacy GD, 2021, AM J OPHTHALMOL, V225, P137, DOI 10.1016/j.ajo.2020.12.001eng
hcfmusp.relation.referenceLacy GD, 2021, AM J OPHTHALMOL, V222, P60, DOI 10.1016/j.ajo.2020.08.032eng
hcfmusp.relation.referenceLacy GD, 2020, OPHTHALMIC GENET, V41, P1, DOI 10.1080/13816810.2020.1731836eng
hcfmusp.relation.referenceLamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220eng
hcfmusp.relation.referenceMcCracken LM, 2014, J BEHAV MED, V37, P1215, DOI 10.1007/s10865-014-9570-9eng
hcfmusp.relation.referenceMennin DS, 2015, PSYCHOL INQ, V26, P80, DOI 10.1080/1047840X.2015.969624eng
hcfmusp.relation.referenceMennin DS, 2013, CLIN PSYCHOL-SCI PR, V20, P258, DOI 10.1111/cpsp.12038eng
hcfmusp.relation.referenceOlatunji BO, 2013, CLIN PSYCHOL-SCI PR, V20, P225, DOI 10.1111/cpsp.12037eng
hcfmusp.relation.referenceOlatunji BO, 2010, CLIN PSYCHOL REV, V30, P642, DOI 10.1016/j.cpr.2010.04.008eng
hcfmusp.relation.referenceOttaviani C, 2016, PSYCHOL BULL, V142, P231, DOI 10.1037/bul0000036eng
hcfmusp.relation.referenceRenna Megan E, 2020, Chronic Stress (Thousand Oaks), V4, p2470547020905787, DOI 10.1177/2470547020905787eng
hcfmusp.relation.referenceSabel BA, 2018, EPMA J, V9, P133, DOI 10.1007/s13167-018-0136-8eng
hcfmusp.relation.referenceSims M, 2016, J EPIDEMIOL COMMUN H, V70, P187, DOI 10.1136/jech-2015-206390eng
hcfmusp.relation.referenceThompson DA, 2015, INVEST OPHTH VIS SCI, V56, P918, DOI 10.1167/iovs.14-16049eng
hcfmusp.relation.referencevan der Aa HPA, 2016, OPHTHAL PHYSL OPT, V36, P584, DOI 10.1111/opo.12313eng
hcfmusp.relation.referenceWilliams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305eng
hcfmusp.relation.referenceWright KD, 2019, NEUROBEHAVIORAL UNDEeng
hcfmusp.relation.referenceWu N, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2020-046194eng
hcfmusp.relation.referenceYioti G, 2017, SEMIN OPHTHALMOL, V32, P428, DOI 10.3109/08820538.2015.1118136eng
hcfmusp.relation.referenceZahid S, 2014, ADV EXP MED BIOL, V801, P131, DOI 10.1007/978-1-4614-3209-8_17eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication5eb87610-bddf-4239-b93f-7279c62f9126
relation.isAuthorOfPublication.latestForDiscovery5eb87610-bddf-4239-b93f-7279c62f9126
Arquivos
Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC